查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1941795

人工智慧诊断市场规模、份额和趋势分析报告：按组件、诊断类型、地区和细分市场划分，预测期为 2026 年至 2033 年

Artificial Intelligence In Diagnostics Market Size, Share & Trends Analysis Report By Component, By Diagnosis Type, By Region, And Segment Forecasts, 2026 - 2033
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10个工作天内

价格

人工智慧诊断市场概述

预计到 2025 年，全球人工智慧诊断市场规模将达到 19.7 亿美元，到 2033 年将达到 96.8 亿美元。

预计从 2026 年到 2033 年，该市场将以 21.74% 的复合年增长率成长。这一市场成长主要由机器学习和深度学习的进步所驱动，这些进步使得更快、更准确的诊断解决方案成为可能。

在肿瘤学、心臟病学和神经病学等领域，对疾病早期检测日益增长的需求正在推动人工智慧技术的应用。例如，2024年2月，皇家飞利浦发布了飞利浦CT 5300，这是一款先进的人工智慧CT系统，专为诊断、介入治疗和筛检设计。这款高度灵活的X光CT系统可提高诊断准确度、简化工作流程并优化系统运转率。

糖尿病、癌症和心血管疾病等慢性病盛行率的上升，以及对早期精准诊断需求的日益增长，是推动市场成长的主要因素。全球癌症发生率的上升导致肿瘤学领域对人工智慧的依赖性增强。根据美国国立卫生研究院 (NIH) 2023 年的估计，美国约有 200 万人被诊断出罹患癌症。乳癌是最常见的癌症，估计女性病例为 297,790 例，男性病例为 2,800 例。同样，根据美国疾病管制与预防中心 (CDC) 的数据，2023 年美国有 919,032 人死于心血管疾病，占所有死亡人数的三分之一。

如此高的发病率增加了诊断工作量。医疗IT基础设施的进步以及云端运算、运算和机器学习演算法的持续技术发展，正推动人工智慧系统与诊断的融合，从而提供高效精准的诊断。这使得医疗服务提供者能够制定及时有效的治疗方案。基于人工智慧的演算法正在病理学和放射学领域中广泛应用。例如，2026年1月，Alpenglow Biosciences和Passnet达成策略合作，共同开发和商业化用于前列腺癌和膀胱癌的3D人工智慧诊断测试。此次合作将推动美国泌尿系统肿瘤学从二维病理学迈向三维病理学，透过整合影像诊断、人工智慧分析和工作流程，提高诊断准确度。

「PathNet在泌尿系统肿瘤学、数位化和人工智慧领域的领先地位，以及其强大的全国性影响力，使其成为将临床3D病理学推向市场的理想合作伙伴。两家公司正在携手开发诊断工具，提供传统2D组织学无法获得的洞见。”

执行长

此外，多种人工智慧工具正被应用于慢性肾臟病（CKD）、肾功能检测以及各种慢性疾病的诊断。例如，2024年5月，Premier Inc.与Astra Zeneca合作启动了「Uncover CKD-Care Collective」倡议。该倡议旨在识别未确诊的CKD患者，提高医疗服务提供者的认知，并帮助美国医疗系统改善CKD的诊断、治疗和管理。透过利用Premier Inc.的PINC人工智慧技术和服务平台，我们将应对CKD未确诊病例日益增多的趋势及其对美国医疗系统带来的经济负担。

目录

第一章：调查方法和范围

第二章执行摘要

第三章：人工智慧在诊断领域的市场变数、趋势与范围

  • 市场谱系展望
  • 市场动态
  • 用于诊断的人工智慧市场分析工具
    • 产业分析：波特五力模型
    • PESTEL 分析
  • 案例研究的启示

第四章：人工智慧诊断市场：按组件分類的估算与趋势分析

  • 按组件分類的市场份额（2025 年和 2033 年）
  • 全球人工智慧诊断市场：基于组件的展望
  • 软体
  • 硬体
  • 服务

第五章：人工智慧诊断市场：按诊断类型分類的估算与趋势分析

  • 按诊断类型分類的市场份额（2025 年和 2033 年）
  • 全球人工智慧诊断市场：按诊断类型分類的展望
  • 心臟病
  • 瘤
  • 病理
  • 辐射
  • 胸部/肺部
  • 神经
  • 其他的

第六章：人工智慧诊断市场：区域估算与趋势分析

  • 区域市场占有率分析（2025 年和 2033 年）
  • 区域市场概览
  • 全球市场概览（按地区划分）
  • 市场规模及预测趋势分析，2021-2033年
  • 北美洲
    • 我们
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麦
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 泰国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第七章 竞争情势

  • Competitor Growth Readiness Index（GRI）, 2025
  • Competitor Capability Matrix, 2025
  • 公司分类
  • 企业市场分析
  • 策略规划
  • 公司简介/列表
    • Key company market share analysis, 2025
    • Siemens Healthineers
    • Zebra Technologies Corp.
    • Riverain Technologies
    • Vuno, Inc.
    • Aidoc
    • NovaSignal Corporation（previously known as Neural Analytics, acquired by NeuraSignal, Inc.）
    • Koninklijke Philips NV
    • Digital Diagnostics, Inc.
    • GE Healthcare
    • AliveCor Inc.
    • F. Hoffmann-La Roche Ltd
Product Code: GVR-4-68038-871-8

Artificial Intelligence In Diagnostics Market Summary

The global artificial intelligence in diagnostics market size was estimated at USD 1.97 billion in 2025 and is projected to reach USD 9.68 billion by 2033, growing at a CAGR of 21.74% from 2026 to 2033. Market growth is driven by advancements in machine learning and deep learning, enabling faster, more accurate diagnostic solutions.

In oncology, cardiology, and neurology, among the areas, the growing demand for early disease detection has led to increased adoption of AI technologies. For instance, in February 2024, Royal Philips introduced the Philips CT 5300, an advanced AI-powered CT system designed for diagnostics, interventional procedures, and screenings. The adaptable X-ray CT system enhances diagnostic accuracy, streamlines workflows, and optimizes system availability.

Rising prevalence of chronic diseases such as diabetes, cancer, cardiovascular disorders, etc., coupled with the increasing demand for early & accurate diagnosis, are significant factors driving market growth. The increasing incidence of cancer globally has led to a growing dependence on AI in the field of oncology. According to the NIH estimates of 2023, approximately 2.0 million individuals in the U.S. are diagnosed with cancer. Breast cancer was the most diagnosed cancer, with an estimated 297,790 cases in women and 2,800 cases in men. Similarly, according to the Centers for Disease Control and Prevention (CDC), 919,032 people died from cardiovascular disease in the U.S. in 2023, equivalent to one in every three deaths.

Such a high prevalence increases the diagnostic workload. Advancements in healthcare IT infrastructure and ongoing technological developments in cloud storage, computing, and machine learning algorithms support the integration of AI-powered systems into diagnostics to provide efficient & accurate diagnoses, allowing care providers to devise timely & appropriate treatment plans. Pathology and radiology services are witnessing a widespread adoption of AI-based algorithms. For instance, in January 2026, Alpenglow Biosciences and PathNet formed a strategic partnership to develop and commercialize 3D AI diagnostic tests for prostate and bladder cancer. The collaboration advances urologic oncology from 2D to 3D pathology in the U.S., integrating imaging, AI analytics, and workflows for enhanced accuracy.

"PathNet's leadership in urologic oncology, digitization, AI, and strong national footprint make them an exceptional partner as we bring clinical 3D pathology to market. Together, we are building diagnostic tools that deliver insights not achievable with conventional 2D histology."

Dr. Nicholas Reder, CEO of Alpenglow Biosciences

In addition, several AI-powered tools are used to diagnose chronic kidney disease (CKD) & kidney function tests, and various chronic diseases. For instance, in May 2024, Premier, Inc. partnered with AstraZeneca to launch the Uncover CKD - Care Collective initiative. The aim is to identify patients with undiagnosed CKD, raise awareness among healthcare providers, and assist U.S. health systems in improving their CKD diagnosis, treatment, and management. Leveraging Premier's PINC AI technology and services platform, the initiative seeks to address the increasing prevalence of undiagnosed CKD and its associated economic burden on the U.S. healthcare system.

Global Artificial Intelligence In Diagnostics Market Report Segmentation

This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends across sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global artificial intelligence in diagnostics market report based on component, diagnosis type, and region:

  • Component Outlook (Revenue, USD Million, 2021 - 2033)
  • Software
  • Hardware
  • Services
  • Diagnosis Type Outlook (Revenue, USD Million, 2021 - 2033)
  • Cardiology
  • Oncology
  • Pathology
  • Radiology
  • Chest and Lung
  • Neurology
  • Others
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Norway
    • Denmark
    • Sweden
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East and Africa (MEA)
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Component
    • 1.1.2. Diagnosis type
    • 1.1.3. Regional scope
    • 1.1.4. Estimates and forecast timeline.
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database.
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
    • 1.6.1. Commodity flow analysis (Model 1)
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Component outlook
    • 2.2.2. Diagnosis type outlook
  • 2.3. Regional outlook
  • 2.4. Competitive Insights

Chapter 3. Artificial Intelligence In Diagnostics Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
    • 3.2.2. Market restraint analysis
    • 3.2.3. Market opportunity analysis
    • 3.2.4. Market challenges analysis
  • 3.3. Artificial Intelligence In Diagnostics Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Economic landscape
      • 3.3.2.3. Social landscape
      • 3.3.2.4. Technological landscape
      • 3.3.2.5. Environmental landscape
      • 3.3.2.6. Legal landscape
  • 3.4. Case Study Insights

Chapter 4. Artificial Intelligence In Diagnostics Market: Component Estimates & Trend Analysis

  • 4.1. Component Market Share, 2025 & 2033
  • 4.2. Segment Dashboard
  • 4.3. Global Artificial Intelligence In Diagnostics Market, By Component Outlook
  • 4.4. Software
    • 4.4.1. Market estimates and forecast, 2021 to 2033 (USD Million)
  • 4.5. Hardware
    • 4.5.1. Market estimates and forecast, 2021 to 2033 (USD Million)
  • 4.6. Services
    • 4.6.1. Market estimates and forecast, 2021 to 2033 (USD Million)

Chapter 5. Artificial Intelligence In Diagnostics Market: Diagnosis Type Estimates & Trend Analysis

  • 5.1. Diagnosis Type Market Share, 2025 & 2033
  • 5.2. Segment Dashboard
  • 5.3. Global Artificial Intelligence In Diagnostics Market, By Diagnosis Type Outlook
  • 5.4. Cardiology
    • 5.4.1. Market estimates and forecast, 2021 to 2033 (USD Million)
  • 5.5. Oncology
    • 5.5.1. Market estimates and forecast, 2021 to 2033 (USD Million)
  • 5.6. Pathology
    • 5.6.1. Market estimates and forecast, 2021 to 2033 (USD Million)
  • 5.7. Radiology
    • 5.7.1. Market estimates and forecast, 2021 to 2033 (USD Million)
  • 5.8. Chest and Lung
    • 5.8.1. Market estimates and forecast, 2021 to 2033 (USD Million)
  • 5.9. Neurology
    • 5.9.1. Market estimates and forecast, 2021 to 2033 (USD Million)
  • 5.10. Others
    • 5.10.1. Market estimates and forecast, 2021 to 2033 (USD Million)

Chapter 6. Artificial Intelligence In Diagnostics Market: Regional Estimates & Trend Analysis, By Component, By Diagnosis Type

  • 6.1. Regional Market Share Analysis, 2025 & 2033
  • 6.2. Regional Market Dashboard
  • 6.3. Global Regional Market Snapshot
  • 6.4. Market Size, & Forecasts Trend Analysis, 2021 to 2033:
  • 6.5. North America
    • 6.5.1. U.S.
      • 6.5.1.1. Key country dynamics
      • 6.5.1.2. Regulatory framework
      • 6.5.1.3. Competitive scenario
      • 6.5.1.4. U.S. market estimates and forecasts, 2021 to 2033 (USD Million)
    • 6.5.2. Canada
      • 6.5.2.1. Key country dynamics
      • 6.5.2.2. Regulatory framework
      • 6.5.2.3. Competitive scenario
      • 6.5.2.4. Canada market estimates and forecasts, 2021 to 2033 (USD Million)
    • 6.5.3. Mexico
      • 6.5.3.1. Key country dynamics
      • 6.5.3.2. Regulatory framework
      • 6.5.3.3. Competitive scenario
      • 6.5.3.4. Mexico market estimates and forecasts, 2021 to 2033 (USD Million)
  • 6.6. Europe
    • 6.6.1. UK
      • 6.6.1.1. Key country dynamics
      • 6.6.1.2. Regulatory framework
      • 6.6.1.3. Competitive scenario
      • 6.6.1.4. UK market estimates and forecasts, 2021 to 2033 (USD Million)
    • 6.6.2. Germany
      • 6.6.2.1. Key country dynamics
      • 6.6.2.2. Regulatory framework
      • 6.6.2.3. Competitive scenario
      • 6.6.2.4. Germany market estimates and forecasts, 2021 to 2033 (USD Million)
    • 6.6.3. France
      • 6.6.3.1. Key country dynamics
      • 6.6.3.2. Regulatory framework
      • 6.6.3.3. Competitive scenario
      • 6.6.3.4. France market estimates and forecasts, 2021 to 2033 (USD Million)
    • 6.6.4. Italy
      • 6.6.4.1. Key country dynamics
      • 6.6.4.2. Regulatory framework
      • 6.6.4.3. Competitive scenario
      • 6.6.4.4. Italy market estimates and forecasts, 2021 to 2033 (USD Million)
    • 6.6.5. Spain
      • 6.6.5.1. Key country dynamics
      • 6.6.5.2. Regulatory framework
      • 6.6.5.3. Competitive scenario
      • 6.6.5.4. Spain market estimates and forecasts, 2021 to 2033 (USD Million)
    • 6.6.6. Norway
      • 6.6.6.1. Key country dynamics
      • 6.6.6.2. Regulatory framework
      • 6.6.6.3. Competitive scenario
      • 6.6.6.4. Norway market estimates and forecasts, 2021 to 2033 (USD Million)
    • 6.6.7. Sweden
      • 6.6.7.1. Key country dynamics
      • 6.6.7.2. Regulatory framework
      • 6.6.7.3. Competitive scenario
      • 6.6.7.4. Sweden market estimates and forecasts, 2021 to 2033 (USD Million)
    • 6.6.8. Denmark
      • 6.6.8.1. Key country dynamics
      • 6.6.8.2. Regulatory framework
      • 6.6.8.3. Competitive scenario
      • 6.6.8.4. Denmark market estimates and forecasts, 2021 to 2033 (USD Million)
  • 6.7. Asia Pacific
    • 6.7.1. Japan
      • 6.7.1.1. Key country dynamics
      • 6.7.1.2. Regulatory framework
      • 6.7.1.3. Competitive scenario
      • 6.7.1.4. Japan market estimates and forecasts, 2021 to 2033 (USD Million)
    • 6.7.2. China
      • 6.7.2.1. Key country dynamics
      • 6.7.2.2. Regulatory framework
      • 6.7.2.3. Competitive scenario
      • 6.7.2.4. China market estimates and forecasts, 2021 to 2033 (USD Million)
    • 6.7.3. India
      • 6.7.3.1. Key country dynamics
      • 6.7.3.2. Regulatory framework
      • 6.7.3.3. Competitive scenario
      • 6.7.3.4. India market estimates and forecasts, 2021 to 2033 (USD Million)
    • 6.7.4. Australia
      • 6.7.4.1. Key country dynamics
      • 6.7.4.2. Regulatory framework
      • 6.7.4.3. Competitive scenario
      • 6.7.4.4. Australia market estimates and forecasts, 2021 to 2033 (USD Million)
    • 6.7.5. South Korea
      • 6.7.5.1. Key country dynamics
      • 6.7.5.2. Regulatory framework
      • 6.7.5.3. Competitive scenario
      • 6.7.5.4. South Korea market estimates and forecasts, 2021 to 2033 (USD Million)
    • 6.7.6. Thailand
      • 6.7.6.1. Key country dynamics
      • 6.7.6.2. Regulatory framework
      • 6.7.6.3. Competitive scenario
      • 6.7.6.4. Singapore market estimates and forecasts, 2021 to 2033 (USD Million)
  • 6.8. Latin America
    • 6.8.1. Brazil
      • 6.8.1.1. Key country dynamics
      • 6.8.1.2. Regulatory framework
      • 6.8.1.3. Competitive scenario
      • 6.8.1.4. Brazil market estimates and forecasts, 2021 to 2033 (USD Million)
    • 6.8.2. Argentina
      • 6.8.2.1. Key country dynamics
      • 6.8.2.2. Regulatory framework
      • 6.8.2.3. Competitive scenario
      • 6.8.2.4. Argentina market estimates and forecasts, 2021 to 2033 (USD Million)
  • 6.9. MEA
    • 6.9.1. South Africa
      • 6.9.1.1. Key country dynamics
      • 6.9.1.2. Regulatory framework
      • 6.9.1.3. Competitive scenario
      • 6.9.1.4. South Africa market estimates and forecasts, 2021 to 2033 (USD Million)
    • 6.9.2. Saudi Arabia
      • 6.9.2.1. Key country dynamics
      • 6.9.2.2. Regulatory framework
      • 6.9.2.3. Competitive scenario
      • 6.9.2.4. Saudi Arabia market estimates and forecasts, 2021 to 2033 (USD Million)
    • 6.9.3. UAE
      • 6.9.3.1. Key country dynamics
      • 6.9.3.2. Regulatory framework
      • 6.9.3.3. Competitive scenario
      • 6.9.3.4. UAE market estimates and forecasts, 2021 to 2033 (USD Million)
    • 6.9.4. Kuwait
      • 6.9.4.1. Key country dynamics
      • 6.9.4.2. Regulatory framework
      • 6.9.4.3. Competitive scenario
      • 6.9.4.4. Kuwait market estimates and forecasts, 2021 to 2033 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Competitor Growth Readiness Index (GRI), 2025
  • 7.2. Competitor Capability Matrix, 2025
  • 7.3. Company Categorization
  • 7.4. Company Market Position Analysis
  • 7.5. Strategy Mapping
  • 7.6. Company Profiles/Listing
    • 7.6.1. Key company market share analysis, 2025
    • 7.6.2. Siemens Healthineers
      • 7.6.2.1. Company overview
      • 7.6.2.2. Financial performance
      • 7.6.2.3. Product benchmarking
      • 7.6.2.4. Strategic initiatives
    • 7.6.3. Zebra Technologies Corp.
      • 7.6.3.1. Company overview
      • 7.6.3.2. Financial performance
      • 7.6.3.3. Product benchmarking
      • 7.6.3.4. Strategic initiatives
    • 7.6.4. Riverain Technologies
      • 7.6.4.1. Company overview
      • 7.6.4.2. Financial performance
      • 7.6.4.3. Product benchmarking
      • 7.6.4.4. Strategic initiatives
    • 7.6.5. Vuno, Inc.
      • 7.6.5.1. Company overview
      • 7.6.5.2. Financial performance
      • 7.6.5.3. Product benchmarking
      • 7.6.5.4. Strategic initiatives
    • 7.6.6. Aidoc
      • 7.6.6.1. Company overview
      • 7.6.6.2. Financial performance
      • 7.6.6.3. Product benchmarking
      • 7.6.6.4. Strategic initiatives
    • 7.6.7. NovaSignal Corporation (previously known as Neural Analytics, acquired by NeuraSignal, Inc.)
      • 7.6.7.1. Company overview
      • 7.6.7.2. Financial performance
      • 7.6.7.3. Product benchmarking
      • 7.6.7.4. Strategic initiatives
    • 7.6.8. Koninklijke Philips N.V.
      • 7.6.8.1. Company overview
      • 7.6.8.2. Financial performance
      • 7.6.8.3. Product benchmarking
      • 7.6.8.4. Strategic initiatives
    • 7.6.9. Digital Diagnostics, Inc.
      • 7.6.9.1. Company overview
      • 7.6.9.2. Financial performance
      • 7.6.9.3. Product benchmarking
      • 7.6.9.4. Strategic initiatives
    • 7.6.10. GE Healthcare
      • 7.6.10.1. Company overview
      • 7.6.10.2. Financial performance
      • 7.6.10.3. Product benchmarking
      • 7.6.10.4. Strategic initiatives
    • 7.6.11. AliveCor Inc.
      • 7.6.11.1. Company overview
      • 7.6.11.2. Financial performance
      • 7.6.11.3. Product benchmarking
      • 7.6.11.4. Strategic initiatives
    • 7.6.12. F. Hoffmann-La Roche Ltd
      • 7.6.12.1. Company overview
      • 7.6.12.2. Financial performance
      • 7.6.12.3. Product benchmarking
      • 7.6.12.4. Strategic initiatives

List of Tables

  • Table 1. List of secondary sources
  • Table 2. List of abbreviations
  • Table 3. Global AI in diagnostics market, by component, 2021 - 2033 (USD Million)
  • Table 4. Global AI in diagnostics market, by diagnosis type, 2021 - 2033 (USD Million)
  • Table 5. North America AI in diagnostics market, by country, 2021 - 2033 (USD Million)
  • Table 6. North America AI in diagnostics market, by component, 2021 - 2033 (USD Million)
  • Table 7. North America AI in diagnostics market, by diagnosis type, 2021 - 2033 (USD Million)
  • Table 8. U.S. AI in diagnostics market, by component, 2021 - 2033 (USD Million)
  • Table 9. U.S. AI in diagnostics market, by diagnosis type, 2021 - 2033 (USD Million)
  • Table 10. Canada AI in diagnostics market, by component, 2021 - 2033 (USD Million)
  • Table 11. Canada AI in diagnostics market, by diagnosis type, 2021 - 2033 (USD Million)
  • Table 12. Mexico AI in diagnostics market, by component, 2021 - 2033 (USD Million)
  • Table 13. Mexico AI in diagnostics market, by diagnosis type, 2021 - 2033 (USD Million)
  • Table 14. Europe AI in diagnostics market, by country, 2021 - 2033 (USD Million)
  • Table 15. Europe AI in diagnostics market, by component, 2021 - 2033 (USD Million)
  • Table 16. Europe AI in diagnostics market, by diagnosis type, 2021 - 2033 (USD Million)
  • Table 17. UK AI in diagnostics market, by component, 2021 - 2033 (USD Million)
  • Table 18. UK AI in diagnostics market, by diagnosis type, 2021 - 2033 (USD Million)
  • Table 19. Germany AI in diagnostics market, by component, 2021 - 2033 (USD Million)
  • Table 20. Germany AI in diagnostics market, by diagnosis type, 2021 - 2033 (USD Million)
  • Table 21. France AI in diagnostics market, by component, 2021 - 2033 (USD Million)
  • Table 22. France AI in diagnostics market, by diagnosis type, 2021 - 2033 (USD Million)
  • Table 23. Italy AI in diagnostics market, by component, 2021 - 2033 (USD Million)
  • Table 24. Italy AI in diagnostics market, by diagnosis type, 2021 - 2033 (USD Million)
  • Table 25. Spain AI in diagnostics market, by component, 2021 - 2033 (USD Million)
  • Table 26. Spain AI in diagnostics market, by diagnosis type, 2021 - 2033 (USD Million)
  • Table 27. Norway AI in diagnostics market, by component, 2021 - 2033 (USD Million)
  • Table 28. Norway AI in diagnostics market, by diagnosis type, 2021 - 2033 (USD Million)
  • Table 29. Denmark AI in diagnostics market, by component, 2021 - 2033 (USD Million)
  • Table 30. Denmark AI in diagnostics market, by diagnosis type, 2021 - 2033 (USD Million)
  • Table 31. Sweden AI in diagnostics market, by component, 2021 - 2033 (USD Million)
  • Table 32. Sweden AI in diagnostics market, by diagnosis type, 2021 - 2033 (USD Million)
  • Table 33. Asia Pacific AI in diagnostics market, by country, 2021 - 2033 (USD Million)
  • Table 34. Asia Pacific AI in diagnostics market, by component, 2021 - 2033 (USD Million)
  • Table 35. Asia Pacific AI in diagnostics market, by diagnosis type, 2021 - 2033 (USD Million)
  • Table 36. Japan AI in diagnostics market, by component, 2021 - 2033 (USD Million)
  • Table 37. Japan AI in diagnostics market, by diagnosis type, 2021 - 2033 (USD Million)
  • Table 38. China AI in diagnostics market, by component, 2021 - 2033 (USD Million)
  • Table 39. China AI in diagnostics market, by diagnosis type, 2021 - 2033 (USD Million)
  • Table 40. India AI in diagnostics market, by component, 2021 - 2033 (USD Million)
  • Table 41. India AI in diagnostics market, by diagnosis type, 2021 - 2033 (USD Million)
  • Table 42. Australia AI in diagnostics market, by component, 2021 - 2033 (USD Million)
  • Table 43. Australia AI in diagnostics market, by diagnosis type, 2021 - 2033 (USD Million)
  • Table 44. South Korea AI in diagnostics market, by component, 2021 - 2033 (USD Million)
  • Table 45. South Korea AI in diagnostics market, by diagnosis type, 2021 - 2033 (USD Million)
  • Table 46. Thiland AI in diagnostics market, by component, 2021 - 2033 (USD Million)
  • Table 47. Thailand AI in diagnostics market, by diagnosis type, 2021 - 2033 (USD Million)
  • Table 48. Latin America AI in diagnostics market, by country, 2021 - 2033 (USD Million)
  • Table 49. Latin America AI in diagnostics market, by component, 2021 - 2033 (USD Million)
  • Table 50. Latin America AI in diagnostics market, by diagnosis type, 2021 - 2033 (USD Million)
  • Table 51. Brazil AI in diagnostics market, by component, 2021 - 2033 (USD Million)
  • Table 52. Brazil AI in diagnostics market, by diagnosis type, 2021 - 2033 (USD Million)
  • Table 53. Argentina AI in diagnostics market, by component, 2021 - 2033 (USD Million)
  • Table 54. Argentina AI in diagnostics market, by diagnosis type, 2021 - 2033 (USD Million)
  • Table 55. Middle East & Africa AI in diagnostics market, by country, 2021 - 2033 (USD Million)
  • Table 56. Middle East & Africa AI in diagnostics market, by component, 2021 - 2033 (USD Million)
  • Table 57. Middle East & Africa AI in diagnostics market, by diagnosis type, 2021 - 2033 (USD Million)
  • Table 58. South Africa AI in diagnostics market, by component, 2021 - 2033 (USD Million)
  • Table 59. South Africa AI in diagnostics market, by diagnosis type, 2021 - 2033 (USD Million)
  • Table 60. Saudi Arabia AI in diagnostics market, by component, 2021 - 2033 (USD Million)
  • Table 61. Saudi Arabia AI in diagnostics market, by diagnosis type, 2021 - 2033 (USD Million)
  • Table 62. UAE AI in diagnostics market, by component, 2021 - 2033 (USD Million)
  • Table 63. UAE AI in diagnostics market, by diagnosis type, 2021 - 2033 (USD Million)
  • Table 64. Kuwait AI in diagnostics market, by component, 2021 - 2033 (USD Million)
  • Table 65. Kuwait AI in diagnostics market, by diagnosis type, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value chain-based sizing & forecasting
  • Fig. 6 Market formulation & validation
  • Fig. 7 Market segmentation
  • Fig. 8 Market snapshot
  • Fig. 9 Segment snapshot
  • Fig. 10 Competitive landscape snapshot
  • Fig. 11 Market trends & outlook
  • Fig. 12 PESTLE analysis
  • Fig. 13 Porter's five forces analysis
  • Fig. 14 AI in diagnostics market: Component outlook and key takeaways
  • Fig. 15 AI in diagnostics market: Component movement analysis
  • Fig. 16 Software market, 2021 - 2033 (USD Million)
  • Fig. 17 Hardware market, 2021 - 2033 (USD Million)
  • Fig. 18 Services market, 2021 - 2033 (USD Million)
  • Fig. 19 AI in diagnostics market: Diagnosis type outlook and key takeaways
  • Fig. 20 AI in diagnostics market: Diagnosis type movement analysis
  • Fig. 21 Cardiology market, 2021 - 2033 (USD Million)
  • Fig. 22 Oncology market, 2021 - 2033 (USD Million)
  • Fig. 23 Pathology market, 2021 - 2033 (USD Million)
  • Fig. 24 Radiology market, 2021 - 2033 (USD Million)
  • Fig. 25 Chest and lung market, 2021 - 2033 (USD Million)
  • Fig. 26 Neurology market, 2021 - 2033 (USD Million)
  • Fig. 27 Others market, 2021 - 2033 (USD Million)
  • Fig. 28 Regional marketplace: Key takeaways
  • Fig. 29 Regional outlook, 2025 & 2033
  • Fig. 30 AI in diagnostics market: Region movement analysis
  • Fig. 31 North America AI in diagnostics market, 2021 - 2033 (USD Million)
  • Fig. 32 US AI in diagnostics market, 2021 - 2033 (USD Million)
  • Fig. 33 Key country dynamics
  • Fig. 34 Canada AI in diagnostics market, 2021 - 2033 (USD Million)
  • Fig. 35 Key country dynamics
  • Fig. 36 Mexico AI in diagnostics market, 2021 - 2033 (USD Million)
  • Fig. 37 Key country dynamics
  • Fig. 38 Europe AI in diagnostics market, 2021 - 2033 (USD Million)
  • Fig. 39 UK AI in diagnostics market, 2021 - 2033 (USD Million)
  • Fig. 40 Key country dynamics
  • Fig. 41 Germany AI in diagnostics market, 2021 - 2033 (USD Million)
  • Fig. 42 Key country dynamics
  • Fig. 43 France AI in diagnostics market, 2021 - 2033 (USD Million)
  • Fig. 44 Key country dynamics
  • Fig. 45 Italy AI in diagnostics market, 2021 - 2033 (USD Million)
  • Fig. 46 Key country dynamics
  • Fig. 47 Spain AI in diagnostics market, 2021 - 2033 (USD Million)
  • Fig. 48 Key country dynamics
  • Fig. 49 Norway AI in diagnostics market, 2021 - 2033 (USD Million)
  • Fig. 50 Key country dynamics
  • Fig. 51 Denmark AI in diagnostics market, 2021 - 2033 (USD Million)
  • Fig. 52 Key country dynamic
  • Fig. 53 Sweden AI in diagnostics market, 2021 - 2033 (USD Million)
  • Fig. 54 Key country dynamics
  • Fig. 55 Asia Pacific AI in diagnostics market, 2021 - 2033 (USD Million)
  • Fig. 56 Japan AI in diagnostics market, 2021 - 2033 (USD Million)
  • Fig. 57 Key country dynamics
  • Fig. 58 China AI in diagnostics market, 2021 - 2033 (USD Million)
  • Fig. 59 Key country dynamics
  • Fig. 60 India AI in diagnostics market, 2021 - 2033 (USD Million)
  • Fig. 61 Key country dynamics
  • Fig. 62 Australia AI in diagnostics market, 2021 - 2033 (USD Million)
  • Fig. 63 Key country dynamics
  • Fig. 64 South Korea AI in diagnostics market, 2021 - 2033 (USD Million)
  • Fig. 65 Key country dynamics
  • Fig. 66 Thailand AI in diagnostics market, 2021 - 2033 (USD Million)
  • Fig. 67 Key country dynamics
  • Fig. 68 Latin America AI in diagnostics market, 2021 - 2033 (USD Million)
  • Fig. 69 Brazil AI in diagnostics market, 2021 - 2033 (USD Million)
  • Fig. 70 Key country dynamics
  • Fig. 71 Argentina AI in diagnostics market, 2021 - 2033 (USD Million)
  • Fig. 72 Key country dynamics
  • Fig. 73 Middle East and Africa AI in diagnostics market, 2021 - 2033 (USD Million)
  • Fig. 74 South Africa AI in diagnostics market, 2021 - 2033 (USD Million)
  • Fig. 75 Key country dynamics
  • Fig. 76 Saudi Arabia AI in diagnostics market, 2021 - 2033 (USD Million)
  • Fig. 77 Key country dynamics
  • Fig. 78 UAE AI in diagnostics market, 2021 - 2033 (USD Million)
  • Fig. 79 Key country dynamics
  • Fig. 80 Kuwait AI in diagnostics market, 2021 - 2033 (USD Million)
  • Fig. 81 Key country dynamics
  • Fig. 82 Company categorization
  • Fig. 83 Strategy mapping
  • Fig. 84 Company market position analysis